All stock lists
Unlock the score
Veru Inc. (NASDAQ:VERU)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
2.22-0.02 (-0.93%)
Market cap
$37.8M
Insider Score
Health Score
Analyst consensus
Listed since
Feb 11, 1999
Website
Insider Score
/ 100
VERU Insider Score
VERU INC. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
VERU analyst forecast
Best analysts covering VERU
- Oppenheimer0%success rate · 5 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
VERU analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-06-04 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-05-15 |
| — | Raymond James | Outperform | — | — | Reiterated | 2025-08-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-01-02 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-12-20 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2024-11-05 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-05-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-05-06 |
| H.C. Wainwright | — | $3.00 | +79.6% | — | 2024-05-03 | |
| Oppenheimer | Outperform | $5.00 | +228.9% | Reiterated | 2024-04-15 | |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-02-08 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-09-27 |
| — | Jefferies | Hold | — | — | Upgraded | 2023-06-07 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-05-15 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-04-06 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2023-03-15 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2023-02-14 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-02-10 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2022-12-07 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2022-12-05 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2022-11-10 |
| — | Brookline Capital | Buy | — | — | Reiterated | 2022-05-18 |
| — | Jefferies | Buy | — | — | Reiterated | 2022-05-13 |
| Oppenheimer | — | $36.00 | +140.8% | — | 2022-04-15 | |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2022-04-12 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2022-04-12 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2021-02-24 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2021-02-11 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2021-02-09 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2020-12-16 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2020-12-15 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2020-12-14 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2020-12-10 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2020-05-14 |
VERU earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-05-13 | -0.31 | -0.13 | $1.9M | $0 |
| 2026-08-10 | -0.32 | -0.30 | $1.7M | $0 |
| 2026-11-26 | -0.25 | 0.00 | $0 | $0 |
| 2026-12-16 | -0.34 | 0.00 | $0 | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.